Company: EDSA
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001171843-25-005236
Chunk: 55

Company: Edesa Biotech, Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 1
Chunk 55
---
			Class A Pref Share

			Risk free interest rate

			4.14
			%

			Expected life

			5 years

			Expected share price volatility

			91.24
			%

			Expected dividend yield

			0.00
			%

Share options 

The Company adopted an Equity Incentive Compensation Plan in 2019 (the 2019 Plan) administered by the independent members of the board of directors, which amended and restated prior plans. Options, restricted shares and restricted share units are eligible for grant under the 2019 Plan. The total number of shares available for issuance under the terms of the 2019 Plan is 2,367,737. The remaining number of shares available to grant at June 30, 2025 is 668,398.

The Company’s 2019 Plan allows options to be granted to directors, officers, employees and certain external consultants and advisers. Under the 2019 Plan, the option term is not to exceed 10 years and the exercise price of each option is determined by the independent members of the board of directors.

Options have been granted under the 2019 Plan allowing the holders to purchase Common Shares of the Company as follows:

			Number of Options (#)

			Weighted Average Exercise Price

			Weighted Average Grant Date Fair Value

			Nine Months Ended June 30, 2025

			Balance - September 30, 2024

			383,040

			$
			24.93

			$
			18.33

			Forfeited

			(4,431
			)

			25.20

			17.69

			Expired

			(374
			)

			246.96

			246.96

			Balance - June 30, 2025

			378,235

			$
			24.71

			$
			18.11

			Nine Months Ended June 30, 2024

			Balance - September 30, 2023

			420,615

			$
			25.60

			$
			18.84

			Granted

			500

			4.10

			3.10

			Forfeited

			(2,401
			)

			15.00

			10